COMMUNIQUÉS West-GlobeNewswire

PhaseBio Announces Positive Preliminary Results from Phase 2a Clinical Trial of PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor in Older and Elderly Subjects
17/06/2019
Top-Line Data Are Consistent with Previously Published Phase 1 Trial MALVERN, Pa. and SAN DIEGO, June 17, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical [...]
Rockwell Medical Announces Proposed Public Offering of Common Stock
17/06/2019
WIXOM, Mich., June 17, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an [...]
Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock
17/06/2019
SOUTH SAN FRANCISCO, Calif., June 17, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the [...]
Delta 9 Announces Public Offering of Convertible Debenture Units
17/06/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. WINNIPEG, Manitoba, June 17, 2019 (GLOBE NEWSWIRE) -- Delta 9 Cannabis Inc. (“ Delta 9 ” or the “ Company ”) (TSXV: NINE [...]
BioSyent to Present at Raymond James Life Sciences and MedTech Conference
17/06/2019
TORONTO, June 17, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that Mr. René Goehrum, President and CEO of BioSyent, will be presenting at the 2019 Raymond James Life [...]
Seminal Clinical Trial in Healthy Adults Demonstrates Promising Preliminary Evidence of PlusCBD™ Oil in Sleep, Wellness, and Weight-Loss Applications
17/06/2019
First-Ever Double-Blind, Randomized Study Titled, “Effects of a CBD-containing Supercritical Fluid Extract of Hemp on Markers of Optimal Wellness, Stress Resilience, and Recovery in Healthy Subjects,” Validates Benefits [...]
Private placement fully subscribed
17/06/2019
BioPorto A/S Other information disclosed according to the rules of the Exchange June 17, 2019 Announcement no. 9 Private placement fully subscribed With reference to company announcement no. 8 of 17 June 2019, the Board [...]
IBA - Transparency Notification
17/06/2019
Louvain-la-Neuve, Belgium, June 17, 2019, 17.35 Summary of the notification IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to [...]
IBA - Publication relative à une notification de transparence
17/06/2019
Louvain-la-Neuve, Belgique, 17 juin 2019, 17.35 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir [...]
Sanofi: information concerning the total number of voting rights and shares, May 2019
17/06/2019
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi : informations relatives au nombre total de droits de vote et d’actions, mai 2019
17/06/2019
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
BioPorto A/S to Increase its Share Capital through a Cash Issue, Private Placement
17/06/2019
June 17, 2019 Announcement no. 8 BioPorto A/S to Increase its Share Capital through a Cash Issue, Private Placement NOT FOR RELEASE , PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, [...]
Ossur Hf : Transactions in relation to share buyback program
17/06/2019
Announcement no. 37/2019 17 June 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors
17/06/2019
First-in-class checkpoint inhibitor BI 765063 licensed to and being developed under a collaboration agreement between Boehringer Ingelheim and OSE Immunotherapeutics Clinical Trial Authorization and dosing of the first [...]
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
17/06/2019
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal confirmed that TearLab’s [...]
Polydex Pharmaceuticals Issues First Quarter Financial Results
17/06/2019
Net Profit up for the Quarter TORONTO, June 17, 2019 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “company”) is pleased to report financial results for the first quarter of fiscal 2020, [...]
Naboso™ Technology and TrueForm Runner Launch the First and Only Proprioceptive Treadmill for Rehabilitation and Performance
17/06/2019
Innovative textured material on a self-powered treadmill aids in balance, stability and post-training injuries NEW YORK, June 17, 2019 (GLOBE NEWSWIRE) -- A patent-pending textured material developed by Naboso™ [...]
Government Can’t Be Trusted with Your Medical Care, States President of the Association of American Physicians and Surgeons (AAPS)
17/06/2019
TUCSON, Ariz., June 17, 2019 (GLOBE NEWSWIRE) -- As the pressure mounts to enact Medicare for All, the president of the Association of American Physicians and Surgeons (AAPS) reviews the checkered history of the U.S. [...]
Precipio CEO Provides Update Letter To Shareholders
17/06/2019
NEW HAVEN, Conn., June 17, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), provides an update to its shareholders. Dear Investors: We are all aware of the recent pricing pressure [...]

Pages